Follow The Filings

ALLO position history

The shares of Allogene Therapeutics (ALLO) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q1: 20,000 shares, $99K, <0.01% of portfolio, New
  2. 2023 Q2: 20,000 shares, $99K, <0.01% of portfolio
  3. 2023 Q3: 20,000 shares, $63K, <0.01% of portfolio
  4. 2023 Q4: 19,194 shares, $62K, <0.01% of portfolio, Reduce −4.0%
  5. 2024 Q1: 19,194 shares, $86K, <0.01% of portfolio
  6. 2024 Q2: 19,194 shares, $45K, <0.01% of portfolio
  7. 2024 Q3: 18,388 shares, $51K, <0.01% of portfolio, Reduce −4.2%
  8. 2024 Q4: 19,194 shares, $41K, <0.01% of portfolio, Add +4.4%
  9. 2025 Q1: 19,194 shares, $28K, <0.01% of portfolio
  10. 2025 Q2: 18,388 shares, $21K, <0.01% of portfolio, Reduce −4.2%
  11. 2025 Q3: 19,194 shares, $24K, <0.01% of portfolio, Add +4.4%
  12. 2025 Q4: 18,388 shares, $25K, <0.01% of portfolio, Reduce −4.2%
  13. 2026 Q1: 17,582 shares, $43K, <0.01% of portfolio, Reduce −4.4%
  14. 2026 Q2: 16,776 shares, $35K, <0.01% of portfolio, Reduce −4.6%
Holdings date Value % of holdings Shares Filing date All 13F holders